Jyoti Chauhan - 26 Jul 2021 Form 4 Insider Report for Landos Biopharma, Inc.

Role: ED, Global Clinical Operations
Signature: /s/ Jyoti Chauhan
Issuer symbol: N/A
Transactions as of: 26 Jul 2021
Net transactions value: +$219,580
Form type: 4
Filing time: 18 Nov 2021, 15:07:49 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LABP	Common Stock	Options Exercise	$219,580	+118,054	+129%	$1.86	209,299	26 Jul 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LABP	Stock Option (right to buy)	Options Exercise	$0	-118,054	-43%	$0.000000	155,681	26 Jul 2021	Common Stock	118,054	$1.86	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	91,245 shares of common stock underlying this option vested and became exercisable on January 1, 2021 and the remaining 182,490 shares of common stock underlying this option vest and become exercisable thereafter in 24 equal monthly installments, subject to the Reporting Person's continuous service with the Issuer on each such date.